Objective:To observe the clinical efficacy of “Shuigu Cataplasm” umbilical compressing combined with Tolvaptan in treatment of refractory cirrhosis ascites. Methods 65 cases of patients with refractory cirrhosis ascites were randomized into treatment group (33 cases) and control group (32 cases). The control group was treated with Tolvaptan orally；the treatment group was treated with “Shuigu Cataplasm” umbilical compressing based on the treatment of control group. Two groups were treated for 14 days. The clinical efficacy was observed. The changes of clinical sign (24h urine volume,abdominal girth,body mass),index of correlation tested with color Doppler ultrasound(blood flow volume of portal vein,blood flow volume of splenic vein,depth of ascites dark space),liver function,levels of sodium in blood and urine.  Results: ①The total effective rate of the treatment group and control group were 81.82%和62.50% respectively; the difference of clinical efficacy between the two groups was statistically significant(P<0.05). ②Compared before treatment and after follow-up,the difference of 24h urine volume,abdominal girth of the two groups were significant(P<0.05)；after the follow-up,the difference of 24h urine volume,abdominal girth between the two groups were significant(P<0.05). ③Compared before and after the treatment,the difference of blood flow volume of portal vein,blood flow volume of splenic vein and depth of ascites dark space of the two groups were significant(P<0.05)；after the treatment,the difference of blood flow volume of portal vein,blood flow volume of splenic vein and depth of ascites dark space between the two groups were significant(P<0.05). ④Compared before and after the treatment,the difference of liver function index of the treatment group were all significant(P<0.05),while only the difference of GGT, TBIL, ALB, A/G levels of control group were significant(P<0.05). After the treatment,the difference of GGT, TBIL, ALB, A/G levels between the two groups were significant(P<0.05).⑤Compared before and after the treatment,the difference of sodium levels in blood and urine of the two groups were significant(P<0.05)；after the treatment,there was no significant difference in sodium levels of blood and urine between the two groups(P>0.05).  Conclusion: “Shuigu Cataplasm” umbilical compressing combined with Tolvaptan in treatment of refractory cirrhosis ascites,can improve the clinical sign,relieve the abdominal water volume of the patients.